Across TCGA pan-cancer cohorts, ZNF192P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ZNF192P2’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where ZNF192P2 RNA is repressed in tumor relative to normal tissue. In most cancer types ZNF192P2 is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

BLCA, HNSC, and PRAD are the cancer types where ZNF192P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF192P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	IV	−0.075	.029	3	view →
HNSC	All	All	+0.017	.015	3	view →
PRAD	All	All	+0.023	.013	2	view →
KIRC	All	All	+0.009	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ZNF192P2 RNA expression & survival · all ZNF192P2 data types